Interview with Professor Jiang Zhongxing: The Challenges and Prospects of the Treatment of Aplastic Anemia

Fenghua "Zheng" Mao, the exhibition "red" map, sponsored by the Chinese Medical Association and the Chinese Medical Association Hematology Branch, hosted by the Henan Provincial Medical Association, and co-organized by the First Affiliated Hospital of Zhengzhou University and the Second Hospital of Lanzhou University, the 18th National Conference on Red Blood Cell Disease (Anemia) was held

Medical Pulse Pass: What is the current status of AA treatment? What are the unmet treatment needs?

Medical Pulse Communication: In recent years, what research progress in the field of AA is worth paying attention to?

Yimaitong: Can you please talk about your vision for the future of AA treatment?

Professor Jiang Zhongxing

• Ph.

  
  

• Director of the Department of Hematology, First Affiliated Hospital of Zhengzhou University

• He is a member of the Hematology Branch of the Chinese Medical Association and the deputy leader of the Red Blood Cell Group

• He is a member of the Hematology Branch of the Chinese Medical Doctor Association

• Member of CSCO China Anti-Leukemia Alliance

• Standing Committee Member of Hematology and Oncology Professional Committee of Chinese Anti-Cancer Association

• He is the chairman of Henan Experimental Hematology Society

• Vice Chairman of the Red Blood Cell Group of the Hematology Branch of the Beijing Cancer Society

• He is the chairman of the Hematology Society of Henan Medical Association and the leader of the red blood cell group

• Chairman of the Blood Disease Translational Medicine Committee of Henan Anti-Cancer Association

• Standing Committee Member of the Hematology Branch of the Chinese Hospital Association

Editor: Quinta

Review: Professor Jiang Zhongxing

Typesetting: Quinta

Execution: moly

Poke "Read the original article" to see more